MAZE EBITDA Growth
Maze Therapeutics Inc · EBITDA Growth
MAZE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-9.59%period ending
MAZE TTM EBITDA YoY % (-295.11% → -9.59%)
Year-over-year change
High-resolution chart · PNG
MAZE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -9.5879% | |
| -312.8763% | |
| -327.0141% | |
| -305.479% | |
| -295.1077% |